{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:47:53Z","timestamp":1761630473070,"version":"3.33.0"},"reference-count":87,"publisher":"Frontiers Media SA","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2709,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1111\/j.1432-2277.2008.00638.x","type":"journal-article","created":{"date-parts":[[2008,2,6]],"date-time":"2008-02-06T07:41:45Z","timestamp":1202283705000},"page":"304-313","source":"Crossref","is-referenced-by-count":29,"title":["The renin angiotensin system blockade in kidney transplantation: pros and cons"],"prefix":"10.3389","volume":"21","author":[{"given":"Josep M.","family":"Cruzado","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Rico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep M.","family":"Griny\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","reference":[{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB1","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1056\/NEJM199912023412303","article-title":"Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant","volume":"341","author":"Wolfe","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB2","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1111\/j.1600-6143.2006.01556.x","article-title":"Potential advantages and limitations of applying the chronic kidney disease classification to kidney transplant recipients","volume":"6","author":"Gill","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB3","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMra011295","article-title":"Strategies to improve long-term outcomes after renal transplantation","volume":"346","author":"Pascual","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB4","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/01.tp.0000235527.81917.fe","article-title":"Cardiovascular complications after renal transplantation and their prevention","volume":"82","author":"Ojo","year":"2006","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB5","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/S0140-6736(03)13638-0","article-title":"Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial","volume":"361","author":"Holdaas","year":"2003","journal-title":"Lancet"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB6","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1111\/j.1523-1755.2004.00919.x","article-title":"Effect of fluvastatin on renal end points in the assessment of Lescol in renal transplant (ALERT) trial","volume":"66","author":"Fellstrom","year":"2004","journal-title":"Kidney Int"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB7","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1111\/j.1600-6143.2005.01105.x","article-title":"Long-term cardiac outcomes in renal transplant recipients receiving fluvastatin: the ALERT extension study","volume":"5","author":"Holdaas","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB8","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1046\/j.1523-1755.2001.0590031158.x","article-title":"Elevated blood pressure predicts the risk of acute rejection in renal allograft recipients","volume":"59","author":"Cosio","year":"2001","journal-title":"Kidney Int"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB9","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1056\/NEJMoa035717","article-title":"Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection","volume":"352","author":"Dragun","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB10","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1007\/s00467-007-0524-0","article-title":"Mechanisms of progression of chronic kidney disease","volume":"22","author":"Fogo","year":"2007","journal-title":"Pediatr Nephrol"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB11","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1681\/ASN.V9101948","article-title":"Chronic allograft nephropathy in the rat is improved by angiotensin II receptor blockade but not by calcium channel antagonism","volume":"9","author":"Amuchastegui","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB12","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1046\/j.1523-1755.1999.00597.x","article-title":"Losartan decreases plasma levels of TGF-beta1 in transplant patients with chronic allograft nephropathy","volume":"56","author":"Campistol","year":"1999","journal-title":"Kidney Int"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB13","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ndt\/gfi265","article-title":"Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases","volume":"21","author":"Ruiz-Ortega","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB14","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1056\/NEJM199606203342507","article-title":"Angiotensin receptors and their antagonists","volume":"334","author":"Goodfriend","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB15","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1093\/ndt\/gfm614","article-title":"Angiotensin AT1 and AT2 receptors the battle for health and disease","volume":"22","author":"Siragy","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB16","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/01.mnh.0000203190.34643.d4","article-title":"Renal and vascular hypertension-induced inflammation: role of angiotensin II","volume":"15","author":"Ruiz-Ortega","year":"2006","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB17","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1172\/JCI112013","article-title":"Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass","volume":"76","author":"Anderson","year":"1985","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB18","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1172\/JCI112521","article-title":"Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension","volume":"77","author":"Zatz","year":"1986","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB19","first-page":"S239","article-title":"Reversing glomerular hypertension stabilizes established glomerular injury in renal ablation","volume":"4","author":"Meyer","year":"1986","journal-title":"J Hypertens Suppl"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0002-9343(85)90077-4","article-title":"Converting enzyme inhibitor therapy limits progressive glomerular injury in rats with renal insufficiency","volume":"79","author":"Meyer","year":"1985","journal-title":"Am J Med"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB21","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/ncpneph0444","article-title":"Mechanisms of disease: the tissue kallikrein-kinin system in hypertension and vascular remodeling","volume":"3","author":"Madeddu","year":"2007","journal-title":"Nat Clin Pract Nephrol"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB22","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1093\/ndt\/gfm363","article-title":"Direct renin inhibitors: the dawn of a new era, or just a variation on a theme?","volume":"22","author":"Segall","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB23","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1172\/JCI117571","article-title":"Nephron supply is a major determinant of long-term renal allograft outcome in rats","volume":"94","author":"Mackenzie","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB24","doi-asserted-by":"crossref","first-page":"F259","DOI":"10.1152\/ajprenal.2000.279.2.F259","article-title":"Influence of nephron mass in development of chronic renal failure after prolonged warm renal ischemia","volume":"279","author":"Cruzado","year":"2000","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB25","first-page":"F367","article-title":"Morphometric analysis of the actions of angiotensin II on renal arterioles and glomeruli","volume":"2","author":"Denton","year":"1992","journal-title":"Am J Physiol"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB26","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1097\/00007890-200209150-00022","article-title":"Intragraft messenger RNA expression of angiotensinogen: relationship with transforming growth factor beta-1 and chronic allograft nephropathy in kidney transplant patients","volume":"74","author":"Mas","year":"2002","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB27","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1111\/j.1600-6143.2007.01928.x","article-title":"Renin angiotensin system blockade in kidney transplantation: a systematic review of the evidence","volume":"7","author":"Hiremath","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB28","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1681\/ASN.2005090955","article-title":"Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation","volume":"17","author":"Heinze","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB29","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1681\/ASN.2006050543","article-title":"No improvement of patient or graft survival in transplant recipients treated with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers: a collaborative transplant study report","volume":"17","author":"Opelz","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB30","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/00007890-198803000-00010","article-title":"Late mortality and morbidity five to eighteen years after kidney transplantation","volume":"45","author":"Toussaint","year":"1988","journal-title":"Transplantation"},{"issue":"Suppl. 3","key":"10.1111\/j.1432-2277.2008.00638.x-BIB31","first-page":"iii62","article-title":"Epidemiology of arterial hypertension in renal transplant patients: changes over the last decade","volume":"19","author":"Campistol","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB32","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/S0041-1345(03)00567-0","article-title":"Risk factors for cardiovascular disease after renal transplantation","volume":"35","author":"Diaz","year":"2003","journal-title":"Transplant Proc"},{"issue":"Suppl. 1","key":"10.1111\/j.1432-2277.2008.00638.x-BIB33","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1681\/ASN.V48s30","article-title":"Hypertension after renal transplantation","volume":"4","author":"First","year":"1994","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB34","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1399-0012.2004.00235.x","article-title":"Cardiovascular disease in stable renal transplant patients in Norway: morbidity and mortality during a 5-yr follow-up","volume":"18","author":"Aakhus","year":"2004","journal-title":"Clin Transplant"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB35","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1053\/j.ajkd.2004.03.013","article-title":"Hypertension after kidney transplantation","volume":"43","author":"Kasiske","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB36","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1016\/S0041-1345(02)03695-3","article-title":"Prevalence and significance of renal artery stenosis and abdominal aortic atherosclerosis early after heart transplantation","volume":"34","author":"Bolad","year":"2002","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB37","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1053\/j.ajkd.2007.04.013","article-title":"ACE inhibitors and persistent left ventricular hypertrophy after renal transplantation: a randomized clinical trial","volume":"50","author":"Paoletti","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB38","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1093\/ndt\/gfh283","article-title":"Left ventricular hypertrophy after renal transplantation, new approach to a deadly disorder","volume":"19","author":"Hernandez","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB39","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/01.ASN.0000104574.04006.08","article-title":"Blood pressure and the survival of renal allografts from living donors","volume":"15","author":"Mange","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB40","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1600-6143.2004.00694.x","article-title":"Association between pulse pressure and cardiovascular disease in renal transplant patients","volume":"5","author":"Fernandez-Fresnedo","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB41","first-page":"S43","article-title":"Role of hypertension in chronic renal allograft dysfunction","volume":"52","author":"Sanders","year":"1995","journal-title":"Kidney Int"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB42","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/ajh\/2.5.341","article-title":"Hypertension in kidney transplant recipients. Effect on long-term renal allograft survival","volume":"1","author":"Cheigh","year":"1989","journal-title":"Am J Hypertens"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB43","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0272-6386(00)70302-7","article-title":"ACE inhibitors and angiotensin II antagonist in renal transplantation: an analysis of safety and efficacy","volume":"35","author":"Stigant","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB44","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0041-1345(01)02818-4","article-title":"Double-blind, crossover, comparative study of doxazosin and enalapril in the treatment of hypertension in renal transplant patients under cyclosporine immunosuppression","volume":"34","author":"Martinez-Castelao","year":"2002","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB45","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1093\/ndt\/gfk058","article-title":"A randomized trial comparing losartan with amlodipine as initial therapy for hypertension in the early post-transplant period","volume":"21","author":"Formica","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB46","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1016\/j.transproceed.2005.03.085","article-title":"Anemia due to losartan in hypertensive renal transplant recipients without posttransplant erythrocytosis","volume":"37","author":"Ersoy","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB47","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/ki.1987.94","article-title":"Uremic cardiomyopathy: an inadequate left ventricular hypertrophy","volume":"31","author":"London","year":"1987","journal-title":"Kidney Int"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB48","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1081\/CEH-200031982","article-title":"Arterial stiffness: pathophysiology and clinical impact","volume":"26","author":"London","year":"2004","journal-title":"Clin Exp Hypertension"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB49","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/MNH.0b013e3282063b86","article-title":"Antihypertensive agents and arterial stiffness: relevance to reducing cardiovascular risk in the chronic kidney disease patient","volume":"16","author":"Agarwal","year":"2007","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB50","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1097\/01.TP.0000086343.32903.A8","article-title":"Successful renal transplantation decreases aortic stiffness and increases vascular reactivity in dialysis patients","volume":"76","author":"Covic","year":"2003","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB51","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1111\/j.1600-6143.2006.01341.x","article-title":"Impaired renal allograft function is associated with increased arterial stiffness in renal transplant recipients","volume":"6","author":"Kneifel","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB52","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1016\/j.transproceed.2005.10.078","article-title":"Arterial elasticity measurement in renal transplant patients under anticalcineurin immunosuppression","volume":"37","author":"Mart\u00ednez-Castelao","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB53","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1399-0012.1995.tb00352.x","article-title":"Erythrocytosis after renal transplantation: risk factors and relationship with GFR","volume":"9","author":"Nankivell","year":"1995","journal-title":"Clin Transplant"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0272-6386(12)80153-3","article-title":"Posttrasplant erythrocytosis: an enigma revisited","volume":"24","author":"Gaston","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB55","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1046\/j.1523-1755.2003.00850.x","article-title":"Posttransplant erythrocytosis","volume":"63","author":"Vlahakos","year":"2003","journal-title":"Kidney Int"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB56","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1111\/j.1600-6143.2004.00612.x","article-title":"Comparative effects of sirolimus and mycophenolate mofetil on erythropoiesis in kidney transplant patients","volume":"4","author":"Augustine","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB57","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/00007890-199010000-00017","article-title":"Multiple site estimates of erythropoietin and renin in polycythemic kidney transplant patients","volume":"50","author":"Aeberhard","year":"1990","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB58","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/00007890-197912000-00012","article-title":"Are the native kidneys responsible for erythrocytosis in renal allorecipients?","volume":"28","author":"Dagher","year":"1979","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB59","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/00007890-199403150-00005","article-title":"Erythrocytosis after renal transplantation. The response to theophylline treatment","volume":"57","author":"Ilan","year":"1994","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB60","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1053\/ajkd.2002.31404","article-title":"Effects of losartan or enalapril on hemoglobin, circulating erythropoietin, and insulin-like growth factor-1 in patients with and without posttransplant erythrocytosis","volume":"39","author":"Wang","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB61","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/00007890-199709270-00021","article-title":"Interference of angiotensin-converting enzyme inhibitors on erythropoiesis in kidney transplant recipients: role of growth factors and cytokines","volume":"64","author":"Morrone","year":"1997","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB62","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00007890-199907150-00012","article-title":"Effects of erythropoietin, angiotensin II, and angiotensin-converting enzyme inhibitor on erythroid precursors in patients with posttransplantation erythrocytosis","volume":"1","author":"Glicklich","year":"1999","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB63","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1016\/S0041-1345(99)00359-0","article-title":"Treatment with losartan in kidney transplant recipients with posttransplant erythrocytosis","volume":"31","author":"Inigo","year":"1999","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB64","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1432-2277.1998.tb00978.x","article-title":"Long-term follow-up of renal transplant recipients treated with losartan for post-transplant erythrosis","volume":"11","author":"Ducloux","year":"1998","journal-title":"Transpl Int"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB65","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/00007890-200108150-00035","article-title":"Comparison of the effects of enalapril and losartan on posttransplantation erythrocytosis in renal transplant recipients: prospective randomized study","volume":"3","author":"Yildiz","year":"2001","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB66","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1097\/00007890-199709150-00023","article-title":"Losartan, and angiotensin-II receptor antagonist, reduces hematocrits in kidney transplant recipients with posttrasplant erythrocytosis","volume":"64","author":"Klaassen","year":"1997","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB67","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0272-6386(12)81129-2","article-title":"Enalapril-associated anemia in renal transplant recipients treated for hypertension","volume":"72","author":"Vlahakos","year":"1991","journal-title":"Am J Kidney Dis"},{"issue":"Suppl. 3","key":"10.1111\/j.1432-2277.2008.00638.x-BIB68","first-page":"iii47","article-title":"Proteinuria: a new marker of long-term graft and patient survival in kidney transplantation","volume":"19","author":"Fern\u00e1ndez-Fresnedo","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB69","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1600-6143.2007.01665.x","article-title":"Urinary albumin excretion and the risk of graft loss and death in proteinuric and non-proteinuric renal transplant recipients","volume":"7","author":"Halimi","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB70","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1056\/NEJM199811123392007","article-title":"Pathophysiology of progressive nephropathies","volume":"339","author":"Remuzzi","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB71","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1111\/j.1523-1755.2004.09220.x","article-title":"Why is proteinuria an ominous biomarker of progressive kidney disease?","volume":"92","author":"Zandi-Nejad","year":"2004","journal-title":"Kidney Int Suppl"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB72","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1016\/j.transproceed.2007.07.005","article-title":"Risk factors and prognosis for proteinuria in renal transplant recipients","volume":"39","author":"Sancho","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB73","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000087842","article-title":"Renal protective effects of the renin-angiotensin-aldosterone system blockade: from evidence-based approach to perspectives","volume":"28","author":"Tylicki","year":"2005","journal-title":"Kidney Blood Press Res"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB74","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1600-6143.2006.01588.x","article-title":"Renal allograft protection with angiotensin II type 1 receptor antagonists","volume":"7","author":"Tylicki","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB75","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1016\/S0140-6736(05)67814-2","article-title":"Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis","volume":"366","author":"Casas","year":"2005","journal-title":"Lancet"},{"issue":"Suppl. 1","key":"10.1111\/j.1432-2277.2008.00638.x-BIB76","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/ndt\/16.suppl_1.117","article-title":"Angiotensin II type 1 (AT1) receptor antagonists in the treatment of hypertension after renal transplantation","volume":"16","author":"Holgado","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB77","doi-asserted-by":"crossref","first-page":"S130","DOI":"10.1046\/j.1523-1755.1998.06826.x","article-title":"Treatment of hypertension after renal transplantation: long-term efficacy of verapamil, enalapril, and doxazosin","volume":"68","author":"Martinez-Castelao","year":"1998","journal-title":"Kidney Int Suppl"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB78","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.transproceed.2005.01.043","article-title":"Renoprotective effect of early inhibition of the renin-angiotensin system in renal transplant recipients","volume":"37","author":"Montanaro","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB79","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0041-1345(01)02806-8","article-title":"Losartan reduces massive proteinuria in kidney transplant patients: a pilot study","volume":"34","author":"Dominguez-Gil","year":"2002","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB80","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/01.tp.0000188137.50178.7d","article-title":"Randomized placebo-controlled study on the effects of losartan and carvedilol on albuminuria in renal transplant recipients","volume":"81","author":"Tylicki","year":"2006","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB81","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1046\/j.1523-1755.1999.00611.x","article-title":"Chronic allograft nephropathy. An update","volume":"56","author":"Paul","year":"1999","journal-title":"Kidney Int"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB82","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/sj.ki.5001709","article-title":"Angiotensin type 1 and type 2 receptor blockade in chronic allograft nephropathy","volume":"70","author":"Lutz","year":"2006","journal-title":"Kidney Int"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB83","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1681\/ASN.V124822","article-title":"Effects of losartan and amlodipine on intrarenal hemodynamics and TGF-beta(1) plasma levels in a crossover trial in renal transplant recipients","volume":"12","author":"Inigo","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB84","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1159\/000072820","article-title":"Effect of angiotensin II receptor blocker on plasma levels of TGF-beta 1 and interstitial fibrosis in hypertensive kidney transplant patients","volume":"23","author":"el-Agroudy","year":"2003","journal-title":"Am J Nephrol"},{"issue":"Suppl.","key":"10.1111\/j.1432-2277.2008.00638.x-BIB85","doi-asserted-by":"crossref","first-page":"s99","DOI":"10.1046\/j.1523-1755.64.s87.15.x","article-title":"Transforming growth factor beta and progression of renal disease","volume":"87","author":"August","year":"2003","journal-title":"Kidney Int"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB86","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1097\/00007890-200112150-00013","article-title":"Sustained improvement of renal graft function for two years in hypertensive renal transplant recipients treated with nifedipine as compared to lisinopril","volume":"72","author":"Midtvedt","year":"2001","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2008.00638.x-BIB87","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1681\/ASN.V281279","article-title":"Studies to determine the basis for hyperkalemia in recipients of a renal transplant who are treated with cyclosporine","volume":"2","author":"Kamel","year":"1992","journal-title":"J Am Soc Nephrol"}],"container-title":["Transplant International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1432-2277.2008.00638.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1432-2277.2008.00638.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,26]],"date-time":"2025-01-26T19:27:01Z","timestamp":1737919621000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1432-2277.2008.00638.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":87,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1432-2277.2008.00638.x","relation":{},"ISSN":["0934-0874","1432-2277"],"issn-type":[{"type":"print","value":"0934-0874"},{"type":"electronic","value":"1432-2277"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}